Assessment of Color Vision in Diabetic Patients

Assessment of Color Vision in Diabetic Patients Before and After the Use of Anti-vegf in the Treatment of Diabetic Macular Edema

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03345667

Enrollment

Registered

2017-11-17

Start date

2017-08-01

Completion date

2017-10-30

Last updated

2017-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy, Diabetic

Brief summary

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Interventions

DRUGlucentis

Use of lucentis and other anti-vegf in patients with diabetic retinopathy

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Having diabetic retinopathy with macular edema

Exclusion criteria

* Not having diabetic retinopathy with macular edema

Design outcomes

Primary

Measure	Time frame	Description
Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema	3 months	Using the Ishihara's test to analise the possible loss of vision

Secondary

Measure	Time frame	Description
Frame between the injections	1 months	Ant-Vegf

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026